HBM Genomics is a VC fund that builds companies that leverage disruptive science and technology to create extraordinary value. We invest in early-stage companies that are pioneering new applications of genomics to transform healthcare. Our current focus is life science tools, clinical diagnostics, therapeutics, and other opportunities addressing significant unmet needs in the Life Sciences.